Publicou 6 edições por ano
ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X
Indexed in
Polymer-Drug Conjugates for Anticancer Drug Delivery
RESUMO
Polymer-drug conjugates (PDCs) are drug delivery systems where one or more drug(s) are covalently attached to the functional groups of the polymer directly or through a spacer. Several anticancer drugs that have been used to synthesize PDCs are currently under clinical trials. PDCs have shown enhanced tumor accumulation, increased therapeutic index, and prolonged circulation, accompanied by a sustained release of the bound drug. Distinct cell uptake mechanisms make PDCs less sensitive to efflux pumps associated with the development of multi-drug resistance. However, the effectiveness of PDCs as a delivery system primarily depends on the drug, polymer, type of linkage, and presence of targeting groups. Due to the availability of different functional groups and spacers, it is possible to control drug release as well as multi-functionalize PDCs, thereby increasing their versatility as drug carriers. Furthermore, active tumor uptake may be achieved by using the concept of drug targeting. However, functionalization alters the in vivo behavior of the polymer, signifying the evaluation of safety and effectiveness of PDCs. Several PDCs are currently being tested in different phases of clinical trials. This review focuses on critical aspects in the design of PDCs when used in cancer drug delivery.
-
Kurniawan Alfin, Gunawan Farrel, Nugraha Adi Tama, Ismadji Suryadi, Wang Meng-Jiy, Biocompatibility and drug release behavior of curcumin conjugated gold nanoparticles from aminosilane-functionalized electrospun poly( N -vinyl-2-pyrrolidone) fibers, International Journal of Pharmaceutics, 516, 1-2, 2017. Crossref
-
Sun Qihang, Zhou Zhuxian, Qiu Nasha, Shen Youqing, Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization, Advanced Materials, 29, 14, 2017. Crossref
-
Zhang Ruinian, Jia Xu, Pei Mingliang, Liu Peng, Facile preparation of pH/reduction dual-responsive prodrug microspheres with high drug content for tumor intracellular triggered release of DOX, Reactive and Functional Polymers, 116, 2017. Crossref
-
Bhattarai Prashant, Vance Dylan, Hatefi Arash, Khaw Ban An, Anin vitrodemonstration of overcoming drug resistance in SKOV3 TR and MCF7 ADR with targeted delivery of polymer pro-drug conjugates, Journal of Drug Targeting, 25, 5, 2017. Crossref
-
Khan Junaid, Alexander Amit, Ajazuddin , Saraf Swarnlata, Saraf Shailendra, Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections, International Journal of Pharmaceutics, 548, 1, 2018. Crossref
-
Xiao Haihua, Yan Lesan, Dempsey Elizabeth M., Song Wantong, Qi Ruogu, Li Wenliang, Huang Yubin, Jing Xiabin, Zhou Dongfang, Ding Jianxun, Chen Xuesi, Recent progress in polymer-based platinum drug delivery systems, Progress in Polymer Science, 87, 2018. Crossref
-
Seifu Muluneh Fromsa, Nath Lila Kanta, Polymer-Drug Conjugates: Novel Carriers for Cancer Chemotherapy, Polymer-Plastics Technology and Materials, 58, 2, 2019. Crossref
-
Hu Yingwen, Stevens David M., Man Sonny, Crist Rachael M., Clogston Jeffrey D., Total drug quantification in prodrugs using an automated elemental analyzer, Drug Delivery and Translational Research, 9, 6, 2019. Crossref
-
Gupta Swati, Pathak Yashwant, Gupta Manish K., Vyas Suresh P., RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted, Artificial Cells, Nanomedicine, and Biotechnology, 47, 1, 2019. Crossref
-
Dzhardimalieva Gulzhian I., Rabinskiy Lev N., Kydralieva Kamila A., Uflyand Igor E., Recent advances in metallopolymer-based drug delivery systems, RSC Advances, 9, 63, 2019. Crossref
-
Mukaya Elie Hembe, Mbianda Xavier Yangkou, Macromolecular Prodrugs Containing Organoiron-Based Compounds in Cancer Research: A Review, Mini-Reviews in Medicinal Chemistry, 20, 9, 2020. Crossref
-
Desai Kashappa Goud H., Polymeric drug delivery systems for intraoral site‐specific chemoprevention of oral cancer, Journal of Biomedical Materials Research Part B: Applied Biomaterials, 106, 3, 2018. Crossref
-
Rizwanullah Md., Amin Saima, Mir Showkat Rasool, Fakhri Khalid Umar, Rizvi Mohd. Moshahid Alam, Phytochemical based nanomedicines against cancer: current status and future prospects, Journal of Drug Targeting, 26, 9, 2018. Crossref
-
Mansur Alexandra A. P., Carvalho Sandhra M., Lobato Zélia I. P., Leite Maria de Fátima, Cunha Armando da Silva, Mansur Herman S., Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy, Bioconjugate Chemistry, 29, 6, 2018. Crossref
-
Li Yihui, Hu Hang, Zhou Qing, Ao Yanxiao, Xiao Chen, Wan Jiangling, Wan Ying, Xu Huibi, Li Zifu, Yang Xiangliang, α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery, ACS Applied Materials & Interfaces, 9, 22, 2017. Crossref
-
Jeong Young-IL, Yoo So Young, Heo Jeong, Kang Dae Hwan, Chlorin e6-Conjugated and PEGylated Immune Checkpoint Inhibitor Nanocomposites for Pulmonary Metastatic Colorectal Cancer, ACS Omega, 4, 20, 2019. Crossref
-
Wang Yaoqi, Xia Heming, Chen Binlong, Wang Yiguang, Rethinking nanoparticulate polymer–drug conjugates for cancer theranostics, WIREs Nanomedicine and Nanobiotechnology, 2022. Crossref
-
Ezazi-Toroghi Sara, Ali Sana Abdul-Jabbar, Bokov Dmitry Olegovich, Dareini Maryam, Bahadori Malihe, Mokaberi Parisa, Amiri-Tehranizadeh Zeinab, Saberi Mohammad Reza, Chamani Jamshidkhan, Interaction behavior between glycated human serum albumin and metformin in the presence of silver nanoparticles: a combination study of spectroscopic, calorimetric and molecular dynamic, Journal of the Iranian Chemical Society, 2022. Crossref
-
McCartin Conor, Dussouillez Candice, Bernhard Chloé, Mathieu Eric, Blumberger Juliette, Dontenwill Monique, Herold-Mende Christel, Idbaih Ahmed, Lavalle Philippe, Bellemin-Laponnaz Stéphane, Kichler Antoine, Fournel Sylvie, Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells, Cancers, 14, 20, 2022. Crossref
-
Mansur Alexandra A. P., Carvalho Sandhra M., Oliveira Luiz Carlos A., Souza-Fagundes Elaine Maria, Lobato Zelia I. P., Leite Maria F., Mansur Herman S., Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells, Pharmaceutics, 14, 10, 2022. Crossref